Table S3 from Proteomic profiling of extracellular matrix components from patient metastases identifies consistently elevated proteins for developing nanobodies that target primary tumors and metastases
Authors:
- Noor JailkhaniNJNoor Jailkhani
- Karl R. ClauserKCKarl R. Clauser
- Howard H. MakHMHoward H. Mak
- Steffen RickeltSRSteffen Rickelt
- Chenxi TianCTChenxi Tian
- Charles A. WhittakerCWCharles A. Whittaker
- Kenneth K. TanabeKTKenneth K. Tanabe
- Stephen R. PurdySPStephen R. Purdy
- Steven A. CarrSCSteven A. Carr
- Richard O. HynesRHRichard O. Hynes
Open Access
- 16 September 2024
- other
- Published by American Association for Cancer Research (AACR)